Clinical term for sarcopenia, the progressive loss of skeletal muscle mass and strength associated with aging. This condition significantly impacts metabolic function and physical autonomy. Understanding this process is crucial for maintaining endocrine balance in later life stages.
Origin
Derived from Greek sarx (flesh) and penia (loss), reflecting a deficit in muscle tissue accumulation over time. In clinical contexts, it relates directly to shifts in anabolic signaling pathways often observed with advancing age. This term situates the physiological decline within a recognizable geriatric framework.
Mechanism
The mechanism involves a complex interplay of reduced anabolic drive, often stemming from diminished growth hormone and testosterone signaling, alongside increased inflammatory cytokines. Furthermore, muscle protein synthesis rates decline relative to breakdown pathways. Mitigating this requires careful modulation of systemic regulators to preserve myofiber integrity.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.